Lung Cancer Europe (LuCE) has developed a set of educational resources covering some of the most relevant topics for the lung cancer patient community.
The full content of this modules is freely accessible by clicking on the links below.
Lung cancer diagnosis and treatment guidelines
Module 1 contains a comprehensive review on what lung cancer is and how is it diagnosed and treated according to the main international guidelines.
R&D Basics (I): Clinical trial design and assessing clinical value
Module 2 contains resources to understand the main basics and principles of clinical trials design, how endpoints are selected and how safety and efficacy are assessed.
R&D Basics (II): Statistics in clinical trials
Module 3 is the second part of the R&D module and contains an explanation on how to interpret and understand data coming out from a clinical study, as well as to understand the statistics behind each particular trial design.
The European regulatory system for medicines and drug regulation
Module 4 contains an explanation on the European regulatory framework for drug approval, how the European Medicines Agency is organize, how does it work and how marketing authorization is granted or denied.
Health Technology Assessment (HTA) and drug pricing
Module 5 contains a review on what is Health Technology Assesment (HTA), what are the different models to assess the value of treatments and therapies and how drug prices are set among the different European countries.
Drug post-marketing follow up and pharmacovigilance
Module 6 provides information on how drugs are closely followed up in Europe once they are in the market to grant their safety. It also covers the explanation on what pharmacovigilance is and what are the mechanisms and actions to follow is any issue is detected with a determined drug.